Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-21-068508

Options or other derivatives

  • Chief Scientific Officer acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brake Rachael Louise · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-12-06 Grant or award : show line 1 in the form Stock Option(right to buy) +500,000 $0.75 2031-12-06 500,000 500,000 D
Loading xslF345X03/doc4.xml…